September/October 2015

Chief Medical Editor's Page

MIGS: the Next Generation

Steven D. Vold, MD, Chief Medical Editor

The Literature

The Literature

Benjamin Abramowitz, MD, and Nisha Chadha, MD

Research Results

Cochlin as a Glaucoma Molecular Biomarker

Research may allow clinicians to initiate treatment before the disease damages patients' optic nerves and visual fields.

Sanjoy K. Bhattacharya, M Tech, PhD, and Richard K. Lee, MD, PhD

Challenging Cases

Not a Routine Case of Pigmentary Dispersion Syndrome or Uveitic Glaucoma

Vikas Chopra, MD; Sourabh Arora, MD; and Brian A. Francis, MD, MS

Residents And Fellows

Appreciating the Journey

Eddie Aminlari, MD

Cover Stories: Stop Glaucoma In Its Tracks

Risk Factors in Glaucomatous Progression

IOP remains the only modifiable risk factor, but fixed, historic risk factors may help clinicians set the initial target pressure and the length of follow-up intervals.

Ta Chen Peter Chang, MD, and Elizabeth A. Hodapp, MD

Am I Getting Worse, Doc?

Practical guidelines for detecting visual field progression in glaucoma.

William H. Bray, MD, and Steven R. Sarkisian Jr, MD

Assessing Imaging Progression

By analyzing the thickness of the retinal nerve fiber layer, optical coherence tomography detects and quantifies glaucomatous progression.

Murray Fingeret, OD

Visual Evoked Potential

Can information from a single diagnostic test help clinicians prevent vision loss?

William Eric Sponsel, MD

Setting Target Pressures

Aim for a range instead of a number to more fully account for each patient's needs.

Inder Paul Singh, MD

Structure and Function in Clinical Practice

Combining structure and function into a single, continuous variable would be advantageous.

Nathan Radcliffe, MD

Monitoring Patients With Advanced Glaucoma

Because they are at high risk of disease progression and blindness, these individuals require special attention.

Darrell WuDunn, MD, PhD

Designing a Clinical Trial for Glaucoma Treatments

Which endpoints should be used?

Michael Waisbourd, MD; Lisa A. Hark, PhD, RD; and L. Jay Katz, MD

Macular Thickness Measurement for the Detection of Glaucomatous Progression

The current evidence suggests a potential use for this novel imaging parameter as a tool in glaucoma monitoring.

Ahmad A. Aref, MD

Determining Factors in Intensifying Glaucoma Management

Take the whole patient into account.

Kelly W. Muir, MD, MHSc

Therapeutics Update

Adding Insult to Injury

The contribution of systemic medication to dry eye disease.

Sejal R. Amin, MD, and Christopher T. Hood, MD

Inside Eyetube.net

How to Place a Suprachoroidal Microstent

Soosan Jacob, MS, FRCS, DNB

News Feature

Q&A With Glaukos CEO Thomas Burns

The process of validating a new category in glaucoma and transitioning from a startup to a public company.

Stephen Daily, Executive Editor, News, BMC

Industry News and Innovations

Practice Pointers

Five Ways to Improve Your Online Reputation

Monitor your online reviews, and respond accordingly to attract patients to your practice.

Cary M. Silverman, MD, MBA, and Shama Hyder